Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariana Muñoz-Esquerre

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Open Respiratory Archives|July 13, 2026
Evidence Update for Tezepelumab to Treat Severe Uncontrolled Asthma, Corticosteroid-dependent Asthma, Chronic Rhinosinusitis With Nasal Polyposis, and Chronic Obstructive Pulmonary Disease. 2nd Barcelona Respiratory Network reportVicente Plaza, Pilar Ausin, Astrid Crespo-Lessmann, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 6, 2020
Sudan red dye: a new agent causing type-2 occupational asthmaDavid Clofent, Miquel de Homdedeu, Mariana Muñoz-Esquerre, et al.
Plos One|May 26, 2017
Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine)Mariana Muñoz-Esquerre, Elisabet Aliagas, Marta López-Sánchez, et al.
Scientific Reports|February 28, 2019
Imbalance in the Expression of Genes Associated with Purinergic Signalling in the Lung and Systemic Arteries of COPD PatientsOriol Careta, Ester Cuevas, Mariana Muñoz-Esquerre, et al.
BMC Pulmonary Medicine|January 12, 2024
Impact of the implementation of a telemedicine program on patients diagnosed with asthmaHéctor Cabrerizo-Carreño, Mariana Muñoz-Esquerre, Salud Santos Pérez, et al.
The Clinical Respiratory Journal|December 15, 2015
Inflammatory markers and circulating extracellular matrix proteins in patients with chronic obstructive pulmonary disease and left ventricular diastolic dysfunctionMarta López-Sánchez, Mariana Muñoz-Esquerre, Daniel Huertas, et al.
Plos One|July 5, 2013
High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional StudyMarta López-Sánchez, Mariana Muñoz-Esquerre, Daniel Huertas, et al.
Respiratory Research|May 30, 2018
Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPDElisabet Aliagas, Mariana Muñoz-Esquerre, Ester Cuevas, et al.
Acta Otorrinolaringologica Espanola|March 23, 2025
Comparison of the EPOS 2020 and POLINA 2.0 guidelines for indicating biologic treatment in adults with chronic rhinosinusitis and nasal polypsMireia Golet, Núria Padullés-Zamora, Alejandro Portillo, et al.
COPD|May 27, 2017
Effectiveness of a Respiratory Day Hospital Program to Reduce Admissions for Exacerbation in Patients with Severe COPD: A Prospective, Multicenter StudyDaniel Huertas, Concepción Montón, Alicia Marín, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Open Respiratory Archives|July 13, 2026
Evidence Update for Tezepelumab to Treat Severe Uncontrolled Asthma, Corticosteroid-dependent Asthma, Chronic Rhinosinusitis With Nasal Polyposis, and Chronic Obstructive Pulmonary Disease. 2nd Barcelona Respiratory Network reportVicente Plaza, Pilar Ausin, Astrid Crespo-Lessmann, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 6, 2020
Sudan red dye: a new agent causing type-2 occupational asthmaDavid Clofent, Miquel de Homdedeu, Mariana Muñoz-Esquerre, et al.
Plos One|May 26, 2017
Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine)Mariana Muñoz-Esquerre, Elisabet Aliagas, Marta López-Sánchez, et al.
Scientific Reports|February 28, 2019
Imbalance in the Expression of Genes Associated with Purinergic Signalling in the Lung and Systemic Arteries of COPD PatientsOriol Careta, Ester Cuevas, Mariana Muñoz-Esquerre, et al.
BMC Pulmonary Medicine|January 12, 2024
Impact of the implementation of a telemedicine program on patients diagnosed with asthmaHéctor Cabrerizo-Carreño, Mariana Muñoz-Esquerre, Salud Santos Pérez, et al.
The Clinical Respiratory Journal|December 15, 2015
Inflammatory markers and circulating extracellular matrix proteins in patients with chronic obstructive pulmonary disease and left ventricular diastolic dysfunctionMarta López-Sánchez, Mariana Muñoz-Esquerre, Daniel Huertas, et al.
Plos One|July 5, 2013
High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional StudyMarta López-Sánchez, Mariana Muñoz-Esquerre, Daniel Huertas, et al.
Respiratory Research|May 30, 2018
Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPDElisabet Aliagas, Mariana Muñoz-Esquerre, Ester Cuevas, et al.
Acta Otorrinolaringologica Espanola|March 23, 2025
Comparison of the EPOS 2020 and POLINA 2.0 guidelines for indicating biologic treatment in adults with chronic rhinosinusitis and nasal polypsMireia Golet, Núria Padullés-Zamora, Alejandro Portillo, et al.
COPD|May 27, 2017
Effectiveness of a Respiratory Day Hospital Program to Reduce Admissions for Exacerbation in Patients with Severe COPD: A Prospective, Multicenter StudyDaniel Huertas, Concepción Montón, Alicia Marín, et al.
Pageof 3